US Map / Connecticut
State CT

Clinical Trials in Connecticut

Recruiting clinical trials with at least one study location in Connecticut. Data updated daily from ClinicalTrials.gov.

Total Trials
192
Recruiting Now
192
← Back to US Map
Top Conditions in Connecticut
Endometrial Cancer (6)Advanced Solid Tumor (6)Breast Cancer (5)Ovarian Cancer (5)Obesity (5)Prostate Cancer (4)Colorectal Cancer (4)NSCLC (4)Opioid Use Disorder (3)Dementia (3)Advanced or Metastatic Solid Tumors (3)Bladder Cancer (3)
NCT07261371 Phase 1
Recruiting
A Study to Compare Blood Levels of Different Dosage Formulations of the Study Me...
Condition
Healthy Volunteer
Enrollment
64 pts
Location
United States
Sponsor
Pfizer
View Trial →
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
View Trial →
NCT02012699 N/A
Recruiting
Integrated Cancer Repository for Cancer Research
Condition
Pancreatic Cancer
Enrollment
999,999 pts
Location
United States
Sponsor
University of Nebraska
View Trial →
NCT06127407 Phase 3
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chon...
Condition
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Enrollment
136 pts
Location
United States, Australia, Belgium
Sponsor
Servier Bio-Innovation LLC
View Trial →
NCT02677064 N/A
Recruiting
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patie...
Condition
Acute Leukemia
Enrollment
1,365 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT05254171 Phase 2, Phase 3
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Ca...
Condition
Pancreatic Cancer Metastatic
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Panbela Therapeutics, Inc.
View Trial →
NCT06555744 Phase 1
Recruiting
A Study of ZW191 in Participants With Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
145 pts
Location
United States, Australia, Japan
Sponsor
Zymeworks BC Inc.
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07062887 N/A
Recruiting
Digital Mindfulness for Young Adults With Type 1 Diabetes
Condition
Type 1 Diabetes (T1D)
Enrollment
10 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT05883163 N/A
Recruiting
STIMIT Activator 1 IDE Study
Condition
Diaphragm Issues
Enrollment
40 pts
Location
United States, Canada
Sponsor
Stimit AG
View Trial →
NCT06188585 N/A
Recruiting
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal U...
Condition
Acute Gastrointestinal Bleeding
Enrollment
278 pts
Location
United States, Canada, Denmark
Sponsor
Medtronic - MITG
View Trial →
NCT04438213 Phase 2
Recruiting
Ertugliflozin in Chronic Heart Failure
Condition
Heart Failure
Enrollment
60 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT05800665 Phase 1
Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Pa...
Condition
Advanced Prostate Cancer
Enrollment
210 pts
Location
United States, Australia, Canada
Sponsor
Genentech, Inc.
View Trial →
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
View Trial →
NCT05919264 Phase 1, Phase 2
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Condition
Cancer
Enrollment
575 pts
Location
United States
Sponsor
Parabilis Medicines, Inc.
View Trial →
NCT04210492 Phase 1, Phase 2
Recruiting
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located...
Condition
Non-small Cell Lung Cancer
Enrollment
36 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT06050252 Phase 2
Recruiting
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resecta...
Condition
Resectable Intrahepatic Cholangiocarcinoma
Enrollment
27 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
Page 8 of 8 — 192 trials total
← Prev